Related Experiment Video
Updated: Jun 15, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage
Manuel Navarro-Oviedo1, Roberto Muñoz-Arrondo2, Beatriz Zandio2
1Laboratory of Atherothrombosis, CIMA, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, IdisNA, Pamplona, Spain.
Abstract:
Matrix metalloproteinases (MMPs) are proteolytic zinc-endopeptidases regulated by tissue Inhibitors of matrix metalloproteinases (TIMPs). We evaluated the potential of MMPs and TIMPs as clinical tools for Intracranial Haemorrhage (ICH). Spontaneous non-traumatic ICH patients were recruited from two hospitals: Complejo Hospitalario de Navarra (CHN = 29) and Vall d´Hebron (VdH = 76). Plasmatic levels of MMP-1, -2, -7, -9, -10 and TIMP-1 and their relationship with clinical, radiological and functional variables were evaluated. We further studied the effect of TIMP-1 (0.05-0.2 mg/Kg) in an experimental tail-bleeding model. In CHN, TIMP-1 was associated with admission-hematoma volume and MMP-7 was elevated in patients with deep when compared to lobar hematoma. In VdH, admission-hematoma volume was associated with TIMP-1 and MMP-7. When data from both hospitals were combined, we observed that an increase in 1 ng/ml in TIMP-1 was associated with an increase of 0.14 ml in haemorrhage (combined β = 0.14, 95% CI = 0.08-0.21). Likewise, mice receiving TIMP-1 (0.2 mg/Kg) showed a shorter bleeding time (p < 0.01). Therefore, the association of TIMP-1 with hematoma volume in two independent ICH cohorts suggests its potential as ICH biomarker. Moreover, increased TIMP-1 might not be sufficient to counterbalance MMPs upregulation indicating that TIMP-1 administration might be a beneficial strategy for ICH.
Insights
Tissue inhibitors of matrix metalloproteinases (TIMPs) show potential as biomarkers for intracranial hemorrhage (ICH). TIMP-1 levels correlate with hematoma volume, and its administration may offer therapeutic benefits in ICH cases.
Area of Science:
- Biochemistry
- Neuroscience
- Clinical Medicine
Background:
- Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play roles in tissue remodeling and are implicated in various pathologies.
- Intracranial hemorrhage (ICH) is a critical condition with significant morbidity and mortality, necessitating improved diagnostic and therapeutic tools.
Purpose of the Study:
- To investigate the potential of MMPs and TIMPs as clinical biomarkers for spontaneous non-traumatic ICH.
- To explore the relationship between plasma levels of specific MMPs and TIMP-1 with clinical, radiological, and functional outcomes in ICH patients.
- To evaluate the effect of TIMP-1 administration on bleeding in an experimental model.
Main Methods:
- Recruitment of 29 patients from Complejo Hospitalario de Navarra (CHN) and 76 from Vall d´Hebron (VdH) with spontaneous non-traumatic ICH.
- Measurement of plasma levels of MMP-1, -2, -7, -9, -10, and TIMP-1.
- Correlation analysis between biomarker levels and clinical, radiological (hematoma volume), and functional variables.
- Experimental study of TIMP-1 (0.05-0.2 mg/Kg) in a mouse tail-bleeding model.
Main Results:
- In CHN, TIMP-1 correlated with admission-hematoma volume, and MMP-7 was higher in deep ICH compared to lobar ICH.
- In VdH, admission-hematoma volume was associated with TIMP-1 and MMP-7.
- Combined analysis showed a significant association between TIMP-1 levels and hematoma volume (β = 0.14, p < 0.05).
- Mice treated with TIMP-1 (0.2 mg/Kg) exhibited significantly reduced bleeding times (p < 0.01).
Conclusions:
- The consistent association of TIMP-1 with hematoma volume in two independent ICH cohorts highlights its potential as a valuable biomarker for ICH.
- Elevated TIMP-1 may not fully counteract MMP upregulation in ICH, suggesting that TIMP-1 administration could be a promising therapeutic strategy to mitigate bleeding.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Increased Intracranial Pressure l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

